Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Start Date
12/20/2023
Completion Date
2/28/2036
Summary
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
Detailed Description
Primary Aims: 1. To evaluate the feasibility of developing a histologic based registry for participants living with metastatic lobular breast cancer. 2. To understand the natural history, treatment patterns, and overall survival in patients with metastatic ILC using modern, real-world data. Secondary Aims: 1. To evaluate the correlation between imaging findings and disease progression. 2. To evaluate the correlation between ctDNA and disease progression. 3. To develop an ongoing platform for evaluating new imaging tools, tumor markers, and participant recruitment for clinical trials. Outline: Participants will be recruited to participate in the registry during a regularly scheduled clinic visit with their treating oncologist, and consented to participate at this time. At each evaluation time point, participants will have a blood draw performed. Participants will be followed until loss to follow up, death, or withdrawal from the registry.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Blood Specimen
Conditions
Locations
University of California, San Diego
San Diego, California 92053
United States
University of California, San Francisco
San Francisco, California 94122
United States
Abramson Cancer Center
Philadelphia, Pennsylvania 19104
United States
MD Anderson Cancer Center
Houston, Texas 77030
United States